Palmitoylethanolamide (PEA)

DIETARY_SUPPLEMENT5 trials

Sponsors

The University of Texas Health Science Center, Houston, RDC Clinical Pty Ltd, Benha University, Ain Shams University

Conditions

AnxietyBipolar DepressionHealthyPain After Extracorporeal Shock Wave LithotripsyPalmitoylethanolamideSafetySleep Disorder (Disorder)Stress

Phase 2

A Trial of the Fatty Acid Amide Hydrolase Inhibitor Palmitoylethanolamide in Bipolar Depression

CompletedNCT06229977

The University of Texas Health Science Center, HoustonBipolar Depression

Start: 2023-05-17End: 2025-07-17Updated: 2025-10-02

Long-Term PEA Safety Study

RecruitingNCT06717867

RDC Clinical Pty LtdHealthy, Safety

Start: 2025-01-22End: 2027-06-30Target: 200Updated: 2025-12-18

Sleep and Stress Study

RecruitingNCT07315516

RDC Clinical Pty LtdAnxiety, Sleep Disorder (Disorder), Stress

Start: 2026-04-07End: 2027-02-01Target: 240Updated: 2026-04-23

Unknown Phase

Palmitoylethanolamide vs Ibuprofen for Pain After ESWL

Not yet recruitingNCT07316660

Benha UniversityPain After Extracorporeal Shock Wave Lithotripsy, Palmitoylethanolamide

Start: 2026-01-01End: 2026-07-01Target: 120Updated: 2026-01-05

Palmitoylethanolamide in Ulcerative Colitis

Not yet recruitingNCT07609810

Ain Shams UniversityUlcerative Colitis (UC)

Start: 2026-08-15End: 2029-02-15Target: 60Updated: 2026-07-14